IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,126,042 | $1,661,605 | $5,321,979 | $4,326,162 |
| - Cash | $11,388 | $16,124 | $33,827 | $7,277 |
| + Debt | $6,960 | $11,652 | $410 | $1,058 |
| Enterprise Value | $1,121,614 | $1,657,133 | $5,288,562 | $4,319,943 |
| Revenue | $4,152 | $4,092 | $2,840 | $1,095 |
| % Growth | 1.5% | 44.1% | 159.4% | – |
| Gross Profit | $232 | $848 | $1,586 | $820 |
| % Margin | 5.6% | 20.7% | 55.8% | 74.9% |
| EBITDA | -$273,857 | -$29,921 | -$29,537 | -$24,657 |
| % Margin | -6,595.7% | -731.2% | -1,040% | -2,251.8% |
| Net Income | -$26,713 | -$32,660 | -$32,550 | -$26,750 |
| % Margin | -643.4% | -798.1% | -1,146.1% | -2,442.9% |
| EPS Diluted | -1.07 | -0.15 | -0.2 | -0.15 |
| % Growth | -613.3% | 25% | -33.3% | – |
| Operating Cash Flow | -$27,090 | -$31,897 | -$27,465 | -$23,294 |
| Capital Expenditures | -$244 | -$267 | -$141 | -$333 |
| Free Cash Flow | -$27,334 | -$32,164 | -$27,606 | -$23,627 |